Ardent Health Partners Inc (NYSE:ARDT) price on Friday, February 28, fall -3.30% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $14.66.
A look at the stock’s price movement, the close in the last trading session was $15.16. The PE ratio in trailing twelve months stood at 9.89. Turning to its 52-week performance, $20.72 and $13.63 were the 52-week high and 52-week low respectively. Overall, ARDT moved -0.27% over the past month.
Ardent Health Partners Inc’s market cap currently stands at around $2.09 billion, with investors looking forward to this quarter’s earnings report slated for in April.
Analysts have a consensus estimate of 1.52B for the company’s revenue for the quarter, with a low and high estimate of 1.48B and 1.54B respectively. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 6.32B, representing a 5.93% jump on that reported in the last financial year.
The technical evaluation for the stock shows the PEG ratio is 0.93, with ARDT’s current price about -0.59% and -4.01% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 48.56, while 7-day volatility ratio is 5.44% and 4.01% in the 30-day chart. Further, Ardent Health Partners Inc (ARDT) has a beta value of 0, and an average true range (ATR) of 0.77. Analysts have given the company’s stock an average 52-week price target of $24, forecast between a low of $24 and high of $24. Looking at the price targets, the low is -63.71% off current price level while to achieve the yearly target high, price needs to move -63.71%. Nonetheless, investors will most likely welcome a -63.71% jump to $24 which is the analysts’ median price.
If we refocus on Ardent Health Partners Inc (NYSE:ARDT), historical trading data shows that trading volumes averaged 338.71K over the past 3 months. The company’s latest data on shares outstanding shows there are 142.75 million shares.
The 83.99% of Ardent Health Partners Inc’s shares are in the hands of company insiders while institutional holders own 11.19% of the company’s shares. Current price change has pushed the stock -14.17% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ARDT stock continues to rise going into the next quarter.
